Clinical Trials Browser

Phase 2 × Leukemia, Hairy Cell × binimetinib × Clear all

NCT04324112 2025-11-10

Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell

NCT04322383 2025-08-26

Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Hairy Cell